PriceTargets.com logo

OTCMKTS:VREOF - Vireo Health International Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $1.33
  • Forecasted Upside: -58.85 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$3.22 As of 02/26/2021 09:28 PM ET
▼ -0.13 (-3.88%)
1 month | 3 months | 12 months
Get New Vireo Health International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VREOF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VREOF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$1.33
▼ -58.85% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Vireo Health International in the last 3 months. The average price target is $1.33, with a high forecast of $2.00 and a low forecast of $0.65. The average price target represents a -58.85% upside from the last price of $3.22.
Buy
The current consensus among 3 contributing investment analysts is to buy stock in Vireo Health International. This rating has held steady since June 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/7/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/6/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/1/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/1/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/30/2020Canaccord GenuityReiterated RatingBuy$2.00
i
9/16/2020Craig HallumInitiated CoverageBuy
i
8/27/2020Canaccord GenuityReiterated RatingBuy$2.00
i
6/17/2020Canaccord GenuityLower Price TargetBuy$2.00 ➝ $1.75
i
5/15/2020Eight CapitalDowngradeBuy ➝ Neutral$0.65
i
(Data available from 3/1/2016 forward)
Vireo Health International logo
Vireo Health International Inc. operates in cannabis industry in the United States. It engages in the cultivation, production, wholesale and retail of medical cannabis products. The company sells and distributes its products through dispensaries. The company is headquartered in Minneapolis, Minnesota.
Read More

Today's Range

Now: $3.22
$3.07
$3.50

50 Day Range

MA: $2.87
$1.95
$3.52

52 Week Range

Now: $3.22
$0.20
$3.84

Volume

354,600 shs

Average Volume

505,082 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Vireo Health International?

The following sell-side analysts have issued research reports on Vireo Health International in the last year: Canaccord Genuity, Craig Hallum, and Eight Capital.
View the latest analyst ratings for VREOF.

What is the current price target for Vireo Health International?

2 Wall Street analysts have set twelve-month price targets for Vireo Health International in the last year. Their average twelve-month price target is $1.33, suggesting a possible downside of 58.9%. Canaccord Genuity has the highest price target set, predicting VREOF will reach $2.00 in the next twelve months. Eight Capital has the lowest price target set, forecasting a price of $0.65 for Vireo Health International in the next year.
View the latest price targets for VREOF.

What is the current consensus analyst rating for Vireo Health International?

Vireo Health International currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VREOF will outperform the market and that investors should add to their positions of Vireo Health International.
View the latest ratings for VREOF.

What other companies compete with Vireo Health International?

Other companies that are similar to Vireo Health International include (CSI), (IMCC), 1933 Industries, 28896, 4Front Ventures, AB Science, Abattis Bioceuticals, Acreage, AFT Pharmaceuticals, Agraflora Organics International, AgraFlora Organics International, Aleafia Health, American Green, Australian Primary Hemp Limited (APH.AX) and Ayr Strategies.

How do I contact Vireo Health International's investor relations team?

The company's listed phone number is 612-314-8995. The official website for Vireo Health International is www.vireohealth.com.